Low incidence of invasive fungal infections in a large observational cohort of patients initiating IL-17 or IL-23 inhibitor therapy, United States, 2016-2022

Nathan C. Bahr, Kaitlin Benedict, Mitsuru Toda, Jeremy A.W. Gold, Shari R. Lipner

Research output: Contribution to journalArticlepeer-review

1 Scopus citations
Original languageEnglish (US)
Pages (from-to)119-122
Number of pages4
JournalJournal of the American Academy of Dermatology
Volume91
Issue number1
DOIs
StatePublished - Jul 2024
Externally publishedYes

Keywords

  • Candida infection
  • Crohn's disease
  • blastomycosis
  • brodalumab
  • candidiasis
  • coccidioidomycosis
  • esophageal candidiasis
  • guselkumab
  • histoplasmosis
  • inflammatory bowel disease
  • interleukin-17 inhibitors
  • interleukin-23 inhibitors
  • invasive fungal infection
  • ixekizumab
  • psoriasis
  • risankizumab
  • secukinumab
  • tildrakizumab
  • ustekinumab

Cite this